Lifeward Ltd. (LFWD) Estados Financieros e Histórico

Lifeward Ltd. (LFWD) — Precio $6.91 HealthcareMedical - Devices — NASDAQ

Últimos resultados publicados:

Estados financieros detallados de Lifeward Ltd. (LFWD): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.

Resumen del Análisis

Lifeward Ltd. registró ingresos de $22.0M en el último ejercicio fiscal, con un CAGR de 5 años del 38.1%.

Márgenes de los últimos 12 meses: margen bruto 36.0%, margen operativo -104.2%, margen neto -141.3%.

Al precio actual de $6.91, LFWD presenta beneficios negativos (P/E no significativo) y un ROE del -236.85%. La capitalización bursátil es de $11M.

Cuenta de Resultados (10 años)

Año2016201720182019202020212022202320242025
Ingresos$5.9M$7.8M$6.5M$4.9M$4.4M$6.0M$5.5M$13.9M$25.7M$22.0M
Coste de Ventas$5.1M$4.7M$3.7M$2.1M$2.2M$3.1M$3.6M$9.4M$17.4M$13.6M
Beneficio Bruto$736000$3.1M$2.8M$2.7M$2.2M$2.9M$1.9M$4.5M$8.2M$8.4M
I+D$9.0M$6.0M$7.3M$5.3M$3.5M$2.9M$4.0M$4.1M$4.6M$3.2M
Generales y Administrativos$22.1M$19.1M$14.7M$11.4M$10.7M$12.6M$17.0M$23.9M$23.1M$22.1M
Gastos Operativos$31.2M$25.1M$22.0M$16.8M$14.2M$15.6M$21.0M$28.1M$27.8M$25.3M
Beneficio Operativo-$30.4M-$22.0M-$19.2M-$14.0M-$12.0M-$12.7M-$19.1M-$23.6M-$19.6M-$16.9M
EBITDA-$29.8M-$21.5M-$18.8M-$13.7M-$11.7M-$12.4M-$18.9M-$20.3M-$24.9M-$19.3M
Gastos por Intereses$2.0M$2.5M$2.4M$1.5M$930000$25000$22000$20000$128000$295000
Beneficio Antes de Impuestos-$32.5M-$24.6M-$21.7M-$15.5M-$12.9M-$12.6M-$19.1M-$22.1M-$28.9M-$20.0M
Impuestos$3000$119000-$5000$7000$51000$94000$467000-$12000$43000-$55000
Beneficio Neto-$32.5M-$24.7M-$21.7M-$15.6M-$13.0M-$12.7M-$19.6M-$22.1M-$28.9M-$19.9M
BPA$-5179.56$-2567.76$-1236.48$-226.80$-68.88$-22.32$-26.40$-31.08$-39.96$-17.16
BPA Diluido$-5179.56$-2567.76$-1236.48$-226.80$-68.88$-22.32$-26.40$-31.08$-39.96$-17.16
Acciones en Circulación (Diluidas)$6273$9622$17523$68583$187603$570434$742308$710657$723983$11.6M

Cuenta de Resultados (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Ingresos$6.2M$5.1M$3.9M$6.6M
Beneficio Bruto$2.7M$1.1M$1.3M$2.7M
Beneficio Operativo-$3.1M-$5.1M-$10.3M-$4.2M
EBITDA-$3.1M-$5.3M-$4.8M-$11.2M
Beneficio Neto-$3.2M-$5.3M-$10.8M-$11.5M
BPA$-2.40$-3.60$-6.70$-4.12
BPA Diluido$-2.40$-3.60$-6.70$-4.12

Balance (10 años)

Año2016201720182019202020212022202320242025
Caja y Equivalentes$23.7M$14.6M$9.5M$16.3M$20.4M$88.3M$67.9M$28.1M$6.9M$2.2M
Inversiones a Corto0000000000
Cuentas por Cobrar$1.3M$1.1M$758000$794000$684000$585000$1.0M$3.1M$6.0M$6.1M
Inventario$3.3M$4.3M$2.6M$3.4M$3.5M$3.0M$2.9M$5.7M$6.7M$5.7M
Activos Corrientes$29.5M$20.9M$13.2M$21.1M$25.2M$92.5M$72.5M$39.2M$21.3M$15.8M
Inmovilizado Material$1.3M$840000$626000$2.2M$1.8M$1.2M$1.0M$3.1M$1.4M$2.1M
Fondo de Comercio0000000$7.5M$7.5M$4.8M
Activos Intangibles0000000$12.5M00
Activos Totales$31.8M$22.9M$15.0M$24.4M$28.1M$94.8M$74.2M$63.2M$30.5M$22.9M
Cuentas por Pagar$3.4M$1.8M$2.3M$2.7M$2.3M$1.4M$1.9M$5.1M$5.0M$5.6M
Deuda a Corto$7.5M$6.4M$1.7M$6.1M0000$858000$2.8M
Pasivos Corrientes$12.4M$9.7M$5.4M$10.2M$4.7M$4.0M$4.8M$11.8M$10.2M$12.0M
Deuda a Largo$10.5M$8.9M$7.0M$1.5M000000
Pasivos Totales$23.5M$19.2M$13.0M$13.6M$6.3M$5.4M$6.1M$16.7M$11.6M$14.5M
Reservas-$106.5M-$131.2M-$152.9M-$168.5M-$181.4M-$194.2M-$213.8M-$235.9M-$264.8M-$284.7M
Patrimonio Neto$8.3M$3.7M$1.9M$10.8M$21.8M$89.4M$68.2M$46.5M$18.8M$8.4M
Deuda Total$18.0M$15.4M$8.7M$8.9M$1.6M$1.1M$897000$1.9M$880000$4.4M
Deuda Neta-$5.7M$785000-$859000-$7.3M-$18.8M-$87.3M-$67.0M-$26.2M-$6.1M$2.2M
Capital Circulante$17.1M$11.2M$7.9M$10.9M$20.6M$88.5M$67.7M$27.4M$11.1M$3.8M

Balance (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Caja y Equivalentes$2.2M$2.2M$11.4M$9.4M
Activos Totales$23.2M$22.9M$33.4M$35.0M
Pasivos Totales$10.4M$14.5M$27.1M$22.8M
Patrimonio Neto$12.8M$8.4M$6.3M$12.2M
Deuda Total$237000$4.4M$8.8M$11.1M

Flujo de Caja (10 años)

Año2016201720182019202020212022202320242025
Beneficio Neto-$32.5M-$24.7M-$21.7M-$15.6M-$13.0M-$12.7M-$19.6M-$22.1M-$28.9M-$16.2M
Amortizaciones$696000$642000$463000$321000$285000$266000$202000$1.8M$3.8M$333000
Compensación en Acciones000$1.1M$749000$833000$993000$1.3M$1.3M$743000
Cambio en Capital Circulante$210000-$2.6M$3.0M-$636000-$211000$197000$88000-$1.3M-$5.0M-$298000
Flujo de Caja Operativo-$27.5M-$22.5M-$14.8M-$14.8M-$12.6M-$11.5M-$17.9M-$20.7M-$21.7M-$16.8M
Inversiones (CapEx)-$452000-$21000-$13000-$22000-$73000-$47000-$25000-$810000-$16000
Adquisiciones$15000000000-$18.1M00
Recompra de Acciones000000-$2.5M-$99200000
Dividendos Pagados0000000000
Flujo de Caja Libre-$28.0M-$22.5M-$14.8M-$14.8M-$12.7M-$11.5M-$17.9M-$20.7M-$21.7M-$16.8M

Flujo de Caja (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Flujo de Caja Operativo-$3.8M-$3.6M-$3.7M-$6.0M
Inversiones (CapEx)0-$1000000
Flujo de Caja Libre-$3.8M-$3.6M-$3.7M-$6.0M
Dividendos Pagados0000
Compensación en Acciones$174000$622000$177000-$177000

Crecimiento y Márgenes (10 años)

Año2016201720182019202020212022202320242025
Crecimiento Ingresos (anual)+32.1%-15.6%-25.5%-9.9%+35.8%-7.6%+151.4%+85.2%-14.1%
Crecimiento Beneficio Neto (anual)+24.0%+12.3%+28.3%+16.6%+1.8%-53.7%-13.1%-30.8%+31.2%
Crecimiento BPA (anual)+50.4%+51.8%+81.7%+69.6%+67.6%-18.3%-17.7%-28.6%+57.1%
Cambio en Acciones (anual)+53.4%+82.1%+291.4%+173.5%+204.1%+30.1%-4.3%+1.9%+1503.0%
Crecimiento FCF (anual)+19.5%+34.3%-0.3%+14.7%+9.1%-55.6%-15.8%-4.7%+22.5%
Margen Bruto12.5%40.0%43.2%55.9%49.8%48.7%34.6%32.1%32.0%38.2%
Margen Operativo-518.7%-283.7%-293.6%-288.3%-273.3%-212.1%-346.6%-170.4%-76.2%-76.7%
Margen EBITDA-507.7%-277.0%-287.1%-281.6%-267.1%-207.7%-343.0%-146.4%-97.1%-87.8%
Margen Neto-553.8%-318.8%-331.2%-319.1%-295.4%-213.5%-355.1%-159.8%-112.8%-90.4%
Margen FCF-476.9%-290.5%-225.9%-304.5%-288.2%-193.0%-325.1%-149.8%-84.6%-76.4%
Tasa Impositiva Efectiva-0.0%-0.5%0.0%-0.0%-0.4%-0.7%-2.4%0.1%-0.1%0.3%

Datos por Acción (10 años)

Año2016201720182019202020212022202320242025
FCF por Acción$-4462.01$-2340.31$-843.87$-216.33$-67.49$-20.19$-24.14$-29.20$-30.00$-1.45
Dividendo por Acción$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Acciones en Circulación (Básicas)$6273$9622$17523$68583$187603$570434$742308$710657$723983$11.6M

Qué mirar en Salud / Farma

El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.

Rentabilidad

Rentabilidad sobre capital-236.85%
Rentabilidad sobre capital invertido-119.56%
Rentabilidad sobre activos-86.96%
Margen bruto35.95%
Margen operativo-104.25%
Margen neto-141.28%

Salud financiera

Deuda / Patrimonio0.21
Ratio corriente1.24
Piotroski F-Score3
Altman Z-Score-15.36

Ratios Clave (10 años)

Año2016201720182019202020212022202320242025
P/E-1.14-0.90-0.30-0.80-1.61-4.63-2.42-2.10-0.52-0.40
P/VC4.476.003.291.150.960.660.701.000.809.55
P/V6.282.870.982.554.749.888.603.350.593.64
Margen Bruto12.5%40.0%43.2%55.9%49.8%48.7%34.6%32.1%32.0%38.2%
Margen Operativo-518.7%-283.7%-293.6%-288.3%-273.3%-212.1%-346.6%-170.4%-76.2%-76.7%
Margen Neto-553.8%-318.8%-331.2%-319.1%-295.4%-213.5%-355.1%-159.8%-112.8%-90.4%

Empresas relacionadas: DHAI · IINN · INAB · LYRA · PTHL · RNAZ · SBFM

Explorar sector: Healthcare · Medical - Devices

Más secciones de LFWD: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos

Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones